Awake Fiberoptic Intubation
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
10 treatments under study, led by Dexmedetomidine
Research Leaders
6 sponsors active, led by Zagazig University
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (7)
Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation
Dexmedetomidine Versus Ketamine-midazolam Sedation in Awake Fiberoptic Intubation in Suspected Difficult Airway
Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation.
Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
Atomization Vs. Nebulization for Airway Topicalization During Awake Nasotracheal Fiberoptic Intubation
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation
Comparison of Two Different Types of "Spray as You go" Technique for Awake Fiberoptic Intubation
Research Network
Common Treatments
- Dexmedetomidine3
- Superior Laryngeal Nerve Block1
- Sevoflurane1
- Atomization With Lidocaine1
- Bronchoscope1
Active Sponsors
- Zagazig University2
- Cairo University1
- Johannes Gutenberg University Mainz1
- Tanta University1
- University of Illinois at Chicago1
Top Investigators
Professor
Lecturer
Anesthesia and surgical intensive care, zagazig university, faculty of medicine
Department of Anesthesiology Head
Anesthesia and surgical intensive care, zagazig university, faculty of medicine
Related Conditions
- Difficult Airway2
- Sedation2
- Sevoflurane1
- Hemimandibulectomy1
- Superior Laryngeal Nerve Block1